Novel antibiotic susceptibility of an RNA polymerase α-subunit mutant in Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Wenjie Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Laboratory for Lingnan Modern Agriculture, South China Agricultural University, Guangzhou 510642, China. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
RNA polymerase (RNAP) is highly conserved and essential for prokaryotic housekeeping activities, making it an important target for the development of new antibiotics. The rpoB gene, encoding a β-subunit of bacterial RNAP, has a well-known association with rifampicin resistance. However, the roles of other RNAP component genes such as rpoA, encoding an α-subunit of RNAP, in antibiotic resistance remain unexplored.
Objectives
To characterize the antibiotic resistance-related role of RpoA.
Methods
We measured the expression of the MexEF-OprN efflux pump in an RpoA mutant using a transcriptional reporter. The MICs of various antibiotics for this RpoA mutant were determined.
Results
We uncover a novel role of antibiotic susceptibility for an RpoA mutant in Pseudomonas aeruginosa. We found that a single amino acid substitution in RpoA resulted in reduced activity of the MexEF-OprN efflux pump, which is responsible for the exportation of various antibiotics, including ciprofloxacin, chloramphenicol, ofloxacin and norfloxacin. This attenuated efflux pump activity, caused by the RpoA mutation, conferred the bacteria further susceptibility to antibiotics regulated by MexEF-OprN. Our work further revealed that certain clinical P. aeruginosa isolates also contained the same RpoA mutation, providing clinical relevance to our findings. Our results elucidate why this new antibiotic-susceptible function of RpoA mutants would have remained undetected in conventional screens for mutants involving antibiotic resistance.
Conclusions
The discovery of antibiotic susceptibility in an RpoA mutant implicates a new therapeutic approach for treating clinical isolates of P. aeruginosa with RpoA mutations, using specific antibiotics regulated by MexEF-OprN. More generally, our work suggests that RpoA could serve as a promising candidate target for anti-pathogen therapeutic purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Laboratory for Lingnan Modern Agriculture, South China Agricultural University, Guangzhou 510642, China.
- College of Plant Protection, Integrative Microbiology Research Center, South China Agricultural University, Guangzhou, 510642, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cai, W., Lu, M., & Dai, W. (2023). Novel antibiotic susceptibility of an RNA polymerase α-subunit mutant in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad207
Vancouver
Cai W, Lu M, Dai W. Novel antibiotic susceptibility of an RNA polymerase α-subunit mutant in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad207
BibTeX
@article{Cai2023,
author = {Cai, Wenjie and Lu, Mingqi and Dai, Weijun},
title = {Novel antibiotic susceptibility of an RNA polymerase α-subunit mutant in Pseudomonas aeruginosa},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad207}
}
EUVIMED